Authorities probing ‘counterfeit’ rabies vaccine, says drug regulator
4 Articles
4 Articles
‘Misbranded’ Abhayrab rabies vaccine seized in Delhi, ‘no part exported to any other country’: What DCGI said
The Delhi Police Crime Branch, along with the Delhi Drugs Control Department, seized a batch of the Abhayrab vaccine (batch number KE25012), which was declared misbranded and not of Standard Quality by the Central Drugs Laboratory (CDL), Kasauli.
Seized Abhayrab vials not manufactured by company: Indian Immunologicals Limited
Indian Immunologicals Limited has asserted that the rabies vaccine vials in question were not produced by their facility. Following a potency test failure, a batch was labeled substandard by the drug regulator. IIL emphasized that the Central Drugs Laboratory in Kasauli had assessed and approved the batch. The company identified seventeen discrepancies between the seized vials and their retention samples.
New Delhi (Uttam Hindu News): India's national drug regulator has banned a batch of 'Abhayrab', a major anti-rabies vaccine widely used across the country. The post Suspicious batch of rabies vaccine 'Abhayrab' causes panic, DCGI issues alert; company says fraudsters making fake vials appeared first on uttamhindu.com.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
